NEW YORK, August 3, 2020 /PRNewswire/ -- Fibronostics, a global diagnostics company, providing non-invasive, algorithmic diagnostics to detect and manage metabolic diseases, announced today Stephen A. Harrison, MD has joined its board of advisors. Dr. Harrison comes to Fibronostics at an...
Fibronostics is a Florida-based SaaS platform that provides solutions such as liver health diagnosis, screening and monitoring for the healthcare industry.